These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 30863041
21. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease. Lee JS, Kim SO, Seo JB, Lee JH, Kim EK, Kim TH, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Lee SW, Huh JW, Oh YM, Lee SD. Lung; 2013 Aug; 191(4):405-12. PubMed ID: 23715996 [Abstract] [Full Text] [Related]
22. Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes. de Weger WW, Klooster K, Ten Hacken NH, van Dijk M, Hartman JE, Slebos DJ. Lung; 2020 Aug; 198(4):629-636. PubMed ID: 32596757 [Abstract] [Full Text] [Related]
23. Spirometry, Static Lung Volumes, and Diffusing Capacity. Vaz Fragoso CA, Cain HC, Casaburi R, Lee PJ, Iannone L, Leo-Summers LS, Van Ness PH. Respir Care; 2017 Sep; 62(9):1137-1147. PubMed ID: 28698266 [Abstract] [Full Text] [Related]
24. Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET. Alter P, Orszag J, Kellerer C, Kahnert K, Speicher T, Watz H, Bals R, Welte T, Vogelmeier CF, Jörres RA. ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32743009 [Abstract] [Full Text] [Related]
25. Diagnostic accuracy of metronome-paced tachypnea to detect dynamic hyperinflation. Lahaije AJ, Willems LM, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF. Clin Physiol Funct Imaging; 2013 Jan; 33(1):62-9. PubMed ID: 23216767 [Abstract] [Full Text] [Related]
26. Determining emphysema in adult patients with COPD-bronchiectasis overlap using a novel spirometric parameter: area under the forced expiratory flow-volume loop. Satici C, Arpinar Yigitbas B, Demirkol MA, Kosar. Expert Rev Respir Med; 2020 Aug; 14(8):839-844. PubMed ID: 32379507 [Abstract] [Full Text] [Related]
27. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. De Backer J, Vos W, Vinchurkar S, Van Holsbeke C, Poli G, Claes R, Salgado R, De Backer W. J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168 [Abstract] [Full Text] [Related]
28. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group. Felipe C, Bartolome C, Miguel D, Victor PP. Chest; 2015 Oct; 148(4):986-994. PubMed ID: 25996450 [Abstract] [Full Text] [Related]
29. Bronchodilator response of advanced lung function parameters depending on COPD severity. Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E. Int J Chron Obstruct Pulmon Dis; 2016 Oct; 11():2939-2950. PubMed ID: 27932874 [Abstract] [Full Text] [Related]
30. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD. Ozgür ES, Nayci SA, Özge C, Taşdelen B. Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294 [Abstract] [Full Text] [Related]
31. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Beeh KM, Singh D, Di Scala L, Drollmann A. Int J Chron Obstruct Pulmon Dis; 2012 Sep; 7():503-13. PubMed ID: 22973092 [Abstract] [Full Text] [Related]
32. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD]. Ulubay G, Görek A, Savaş S, Oner Eyüboğlu F. Tuberk Toraks; 2005 Sep; 53(4):340-6. PubMed ID: 16456732 [Abstract] [Full Text] [Related]
33. Ratio of Maximal Inspiratory to Expiratory Flow Aids in the Separation of COPD from Asthma. Okazawa M, Imaizumi K, Mieno Y, Takahashi H, Paré PD. COPD; 2020 Jun; 17(3):230-239. PubMed ID: 32237910 [Abstract] [Full Text] [Related]
34. Plethysmographic lung volumes in children with sighing dyspnea. Wong KS, Chiu CY, Huang YH, Huang LJ. Pediatr Int; 2009 Jun; 51(3):405-8. PubMed ID: 19419494 [Abstract] [Full Text] [Related]
35. Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases. Nasr A, Papapostolou G, Jarenbäck L, Romberg K, Tunsäter A, Ankerst J, Bjermer L, Tufvesson E. Clin Physiol Funct Imaging; 2024 Nov; 44(6):426-435. PubMed ID: 38873744 [Abstract] [Full Text] [Related]
36. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium. Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V. Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851 [Abstract] [Full Text] [Related]
37. Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease. Mahut B, Caumont-Prim A, Plantier L, Gillet-Juvin K, Callens E, Sanchez O, Chevalier-Bidaud B, Bokov P, Delclaux C. Int J Chron Obstruct Pulmon Dis; 2012 Jan; 7():165-71. PubMed ID: 22500118 [Abstract] [Full Text] [Related]
38. Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease. Martinez L, Rodrigues D, Donária L, Furlanetto KC, Machado FVC, Schneider LP, Ribeiro M, Hernandes NA, Pitta F. Lung; 2019 Feb; 197(1):9-13. PubMed ID: 30374589 [Abstract] [Full Text] [Related]
39. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Belman MJ, Botnick WC, Shin JW. Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581 [Abstract] [Full Text] [Related]